InvestorsHub Logo
Followers 29
Posts 3391
Boards Moderated 1
Alias Born 06/09/2004

Re: None

Monday, 10/16/2017 7:46:04 AM

Monday, October 16, 2017 7:46:04 AM

Post# of 474
Sangamo Therapeutics is involved in the quickly growing field of genome editing, but with a twist

https://www.clinicalleader.com/doc/in-genome-editing-trials-the-effects-last-a-lifetime-0001?sthash.QAS2HPmw.mjjo


Never buy or sell based on my posts.Always consult with a licensed securities professional before you buy or sell any security.My posts are opinions only.Never use them as due diligence.My positions are subject to change without notice.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SGMO News